Navigation Links
ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Date:8/27/2007

ImmuneRegen and TGen Continue Testing Possible Treatment for Acute Radiation Syndrome or Radiotherapy Adjuvant Likely Targeting Adult Stem

Cells in Bone Marrow

SCOTTSDALE, Ariz., Aug. 27 /PRNewswire-FirstCall/ -- ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC Bulletin Board: IRBO), today announced that initial studies at TD2 (TGen Drug Development Services), an affiliate of The Translational Genomics Research Institute (TGen) have found ImmuneRegen's Radilex (TM) to protect mice from the near total destruction of circulating white blood cells following radiation exposure. These findings support past data and provide further insight into possible mechanisms underlying the activity of Radilex as well as suggest possible therapeutic areas in which Radilex could play a role as a potential treatment.

In previous studies of lethally irradiated mice, Radilex was shown to enhance survival and increase white blood cells in surviving animals. In the recent studies, a sub-lethal dose of radiation induced a 90-95% decrease in circulating white blood cell levels. Administered shortly following radiation exposure, Radilex was able to subsequently increase circulating levels of monocytes, granulocytes and lymphocytes in all treated animals.

"The results of this study have strengthened our confidence that Radilex(TM) may prove to be a life saving treatment candidate as well as a drug and treatment enhancement candidate," says Michael K. Wilhelm, Co-Founder and CEO of ImmuneRegen BioSciences, Inc. "We are very happy that our relationship with TGen continues to develop a promising collection of data on Radilex's ability to potentially preserve human life after lethal or sub-lethal exposure to radiation."

Low circulating white blood cell counts (leukopenia or leukocytopenia) can be due to a number of causes, among them infections (including certain viral infections such as
'/>"/>

SOURCE ImmuneRegen BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
2. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22 2015 /CNW/ - The Taskforce representing ... of all the hard work that the Minister and Health ... months. This program recognizes the needs of the thalidomide survivors, ... $75,000 a year, tax free, with annual adjustments for inflation. ... for annual payments of $100,000 based on the severity of ...
(Date:5/22/2015)... /CNW/ - More than fifty years ago, Thalidomide was approved ... expectant mothers. Tragically, Thalidomide caused serious and permanent physical and ... Support has been provided to survivors over the years from ... in 1991 and settlements from drug companies. ... to provide support, we have a clear moral obligation to ...
(Date:5/22/2015)... -- The Assistance Fund announces the addition of its ... for copay to individuals diagnosed with Melanoma. ... the Melanoma Copay Assistance Program to our portfolio of ... "With each additional program we are closer to achieving ... one is denied access to medications due to an ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3The Assistance Fund Adds Melanoma Assistance Program 2
... - Results Further Support the Clinical Profile of ... Survival of Patients,With Hormone Refractory Prostate Cancer (HRPC), ... therapeutics company,today announced that the primary objective of ... The study showed that even single doses of,Alpharadin ...
... involved in 10-year study, CHICAGO, Aug. 27 ... issue of the New England Journal of Medicine,found that ... gestation reduced the risk of cerebral palsy by 50 ... was,conducted in 18 centers in the U.S., including Northwestern ...
Cached Medicine Technology:Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 3Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 4National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3
(Date:5/25/2015)... 26, 2015 The National Association ... a 2015-2016 inductee into its VIP Professional Woman of ... distinction for leadership in dentistry. NAPW is the nation's ... than 700,000 members and over 200 operating local chapters. ... exceptional group of professional women,” said NAPW President Star ...
(Date:5/25/2015)... York, New York (PRWEB) May 25, 2015 ... distributor of patented products, launches The Preventer, a home ... from the dangers of fire. , "House fires cost ... says Scott J. Cooper, CEO and Creative Director of ... home fire deaths result from homes that have no ...
(Date:5/25/2015)... HomeCare is proud to announce that David Allerby, Co-Founder ... Iwamoto, Co-Founder & CMO, are Finalists for the Ernst ... Greater Los Angeles. The award is presented by EY ... and a personal commitment to their communities. , “Our ... of our organization,” said Co-Founder & CEO, David Allerby, ...
(Date:5/25/2015)... May 25, 2015 Stanley Consultants ... awards for design of the wastewater treatment expansion ... project received a National Recognition Award from the American ... from ACEC – Iowa. Competitions held by the ... The $50.2 million expansion is Iowa City’s largest public ...
(Date:5/25/2015)... Rafael, CA (PRWEB) May 25, 2015 Join ... for a free two-hour instructional clinic. Irish National Player, ... campers and give them a taste of her coaching style. ... Anselmo and Novato. Camps in Novato are at Lynwood Elmentary ... , Novato High School - June 6th, 2015 - ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2
... has launched, dedicated to all aspiring souls with interest ... and wellness//. Founded by a personal fitness trainer turned ... inspired by her own healing process, it became the ... that educates, inspires, nurtures, and stimulates the mind, body, ...
... Thomas Jefferson University Hospital are combining efforts to determine if ... forms of migraine headaches. ,Investigators from the Jefferson ... in a blinded study to determine if closing a Patent ... allow blood to flow between the right and left sides ...
... Easter morning, two casual care support staff members allegedly assaulted ... Porirua//, New Zealand. Earlier another member of ... unit. All three are under suspension. ,Staff and ... under investigation from officials of the Capital and District Health ...
... Drug Administration (FDA) is alerting health care professionals and ... emerging// drug safety information. The broadcasts, commonly known as ... audio players. ,The service is part of ... communications concerning the safety of marketed medications when ...
... with the antiviral drug Tamiflu have the best chances of ... the World Health Organization (WHO) said on Friday. ... of international experts who met last month in Turkey to ... some countries to use steroids as well. ,"Corticosteroid ...
... exposed when thirty poor women of the fishing community, living ... The 1994 Transplant of Human Organ Act ... be allowed to donate kidneys for transplantation. However a recent ... to indicate that several leading hospitals in the state encouraged ...
Cached Medicine News:Health News:Jefferson Researchers Want to Learn If Heart Defect 'at Heart' of Some Migraines 2Health News:Mentally Ill Patients - Victims Of Assault By Their Caregivers 2Health News:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2Health News:Tamiflu Key to Treat Bird Flu, Avoid Steroids: WHO 2Health News:Kidney Trade: Curbing the Sale 2Health News:Kidney Trade: Curbing the Sale 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: